225 related articles for article (PubMed ID: 6334270)
1. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
2. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
[TBL] [Abstract][Full Text] [Related]
3. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in patients with diabetes mellitus.
Abrass CK; Heber D; Lieberman J
Clin Exp Immunol; 1983 Apr; 52(1):164-72. PubMed ID: 6305541
[TBL] [Abstract][Full Text] [Related]
5. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
Sobel A; Gabay Y; Lagrue G
Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
[TBL] [Abstract][Full Text] [Related]
7. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
8. Association between circulating immune complexes and renal disease in New Zealand mice.
Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
[TBL] [Abstract][Full Text] [Related]
9. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
10. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
12. The effect of a protein meal on three fluid-phase assays for circulating immune complexes.
Elkon KB; Lanham JG; Dash AC; Hughes GR
Clin Exp Immunol; 1981 Aug; 45(2):279-82. PubMed ID: 6976243
[TBL] [Abstract][Full Text] [Related]
13. [Circulating immune complexes in a population of subjects seropositive for rheumatoid factor].
Aureli G; Battista V; Bianchi L; Bolzonetti A; Cipriani A; Carnevali GF; Caschera F; Caputo B; Danieli G; Corvetta A
Boll Ist Sieroter Milan; 1982; 61(5):367-74. PubMed ID: 6985415
[TBL] [Abstract][Full Text] [Related]
14. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significances of circulating immune complexes in hematologic disorders--detection by C1q deviation test and anti-antibody inhibition test].
Yasuda M; Nobunaga M; Sakai K; Motomura S; Ibayashi H; Kozuru M
Rinsho Ketsueki; 1983 Apr; 24(4):448-55. PubMed ID: 6604173
[No Abstract] [Full Text] [Related]
16. The detection of complement binding immune complexes by means of 51Cr-labelled indicator cells.
Varga A; Kasper M; Stosiek P
Allerg Immunol (Leipz); 1986; 32(3):205-14. PubMed ID: 2947445
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
18. [The liquid phase C1q binding assay and its clinical application].
Cheng PZ; Dong Y; Zhang NZ; Ji D; Dai X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):69-71. PubMed ID: 2954693
[No Abstract] [Full Text] [Related]
19. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes detected by C1q solid phase assay in leprosy.
Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]